Cargando…
二甲双胍通过激活腺苷酸活化蛋白激酶（AMPK）的抗肿瘤机制
Metformin, as a traditional oral hypoglycemic agent, is commonly used in the clinical treatment for type 2 diabetes. Recently, a large number of epidemiological researches have shown that metformin could reduce the tumor morbidity of type 2 diabetes, moreover, it has also been indicated that metform...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000667/ https://www.ncbi.nlm.nih.gov/pubmed/23945247 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.08.07 |